Digital Health (Apr 2022)

Smartphone movement sensors for the remote monitoring of respiratory rates: Technical validation

  • Sophie Valentine,
  • Adam C. Cunningham,
  • Benjamin Klasmer,
  • Mohammad Dabbah,
  • Marko Balabanovic,
  • Mert Aral,
  • Dan Vahdat,
  • David Plans

DOI
https://doi.org/10.1177/20552076221089090
Journal volume & issue
Vol. 8

Abstract

Read online

Background Mobile health (mHealth) offers potential benefits to both patients and healthcare systems. Existing remote technologies to measure respiratory rates have limitations such as cost, accessibility and reliability. Using smartphone sensors to measure respiratory rates may offer a potential solution to these issues. Objective The aim of this study was to conduct a comprehensive assessment of a novel mHealth smartphone application designed to measure respiratory rates using movement sensors. Methods In Study 1, 15 participants simultaneously measured their respiratory rates with the app and a Food and Drug Administration-cleared reference device. A novel reference analysis method to allow the app to be evaluated ‘in the wild’ was also developed. In Study 2, 165 participants measured their respiratory rates using the app, and these measures were compared to the novel reference. The usability of the app was also assessed in both studies. Results The app, when compared to the Food and Drug Administration-cleared and novel references, respectively, showed a mean absolute error of 1.65 ( SD = 1.49) and 1.14 (1.44), relative mean absolute error of 12.2 (9.23) and 9.5 (18.70) and bias of 0.81 (limits of agreement = –3.27 to 4.89) and 0.08 (–3.68 to 3.51). Pearson correlation coefficients were 0.700 and 0.885. Ninety-three percent of participants successfully operated the app on their first use. Conclusions The accuracy and usability of the app demonstrated here in individuals with a normal respiratory rate range show promise for the use of mHealth solutions employing smartphone sensors to remotely monitor respiratory rates. Further research should validate the benefits that this technology may offer patients and healthcare systems.